Filing Details

Accession Number:
0001415889-22-008937
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-22 17:12:50
Reporting Period:
2022-08-18
Accepted Time:
2022-08-22 17:12:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411685 Vistagen Therapeutics Inc. VTGN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901014 B Jerry Gin C/O Vistagen Therapeutics, Inc.
343 Allerton Avenue
South San Francisco CA 94080
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-18 100,000 $0.18 100,000 No 4 P Direct
Common Stock Acquisiton 2022-08-18 100,000 $0.18 100,000 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 100,000 Indirect By Jermax, LLC
Common Stock 100,000 Indirect By Pegmax, LLC
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1772 to $0.1805, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  2. Jermax, LLC is wholly owned and controlled by the Reporting Person.
  3. Pegmax, LLC is wholly owned and controlled by the Reporting Person's spouse.